Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedPage now displays a new revision indicator: Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedUI text updates were added: 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The corresponding older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, indicating a minor administrative update to the study record with no substantive changes to the study design, criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a consolidated Locations section listing all participating sites (US states and Ontario). Removed the individual state location subsections and the per-location links. Revision: v3.3.3.SummaryDifference2%

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.